Tag: CAPA

Analysis of Disintegration Time Failures During Campaign Changeovers In pharmaceutical manufacturing, particularly during the production of tablets, disintegration time is a critical quality parameter. A failure in achieving the specified…

Addressing Disintegration Time Failures During Compression: A Root Cause Investigation Guide In the realm of pharmaceutical manufacturing, particularly in tablet formulation, discrepancies in disintegration time during compression can lead to…

Managing Friability Failures Following Tooling Changes to Mitigate FDA Inspection Risks Friability failures in tablet manufacturing can pose significant risks to product quality and regulatory compliance, often triggering investigations and…

Investigating Tablet Chipping Complaints During High-Speed Production Runs Tablet chipping during high-speed runs presents significant challenges in pharmaceutical manufacturing, leading to product integrity issues and quality complaints. As a manufacturing…

Investigating Black Specks Detected Following Tooling Changes in Tablet Manufacturing In the competitive landscape of pharmaceutical manufacturing, maintaining product integrity is paramount. Instances of contamination or defects, such as black…

Root Cause Analysis for Tablet Capping During Compression: A Comprehensive Guide Tablet capping, a defect in tablet manufacturing that involves the separation of the tablet cap from its body, often…

Understanding and Addressing Dissolution Failures During Stability Pulls Dissolution failure during stability pulls can present a significant challenge in pharmaceutical manufacturing, particularly in tablets. When faced with an out-of-specification (OOS)…

Investigation of Tablet Capping During Stability Pull: Evaluating Process and Formulation When conducting stability pulls in pharmaceutical manufacturing, it’s critical to ensure product integrity. An alarming observation, such as tablet…

Analyzing Friability Failures After Scale-Up: A Structured Investigation Approach Manufacturers in the pharmaceutical industry frequently face challenges, particularly during scale-up processes. One common issue is friability failure, which can lead…

Understanding Disintegration Time Failures During Campaign Changeover and Their Regulatory Implications Manufacturing defects, particularly in the context of disintegration time during campaign changeovers, pose significant challenges to pharmaceutical manufacturers. Such…

Investigating Content Uniformity OOS During Campaign Changeover in Pharmaceutical Manufacturing Pharmaceutical manufacturing processes are highly regulated and require an unwavering focus on quality. One common problem that arises is the…

Assessing Friability Failures During Stability Pull: A Comprehensive Investigation Approach In the dynamic landscape of pharmaceutical manufacturing, friability failures during stability pulls can lead to significant regulatory scrutiny and production…